Evotec Historical Balance Sheet

EVO Stock

USD 3.88 0.14 3.48%

Trend analysis of Evotec SE ADR balance sheet accounts such as Other Assets of 1.09 or Common Stock Shares Outstanding of 222.1 M provides information on Evotec SE's total assets, liabilities, and equity, which is the actual value of Evotec SE ADR to its prevalent stockholders. By breaking down trends over time using Evotec SE balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Evotec SE ADR latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Evotec SE ADR is a good buy for the upcoming year.

Evotec SE Inventory

32.68 Million

Build AI portfolio with Evotec Stock

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evotec SE ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

About Evotec Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Evotec SE ADR at a specified time, usually calculated after every quarter, six months, or one year. Evotec SE Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Evotec SE and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Evotec currently owns. An asset can also be divided into two categories, current and non-current.

Evotec SE Balance Sheet Chart

At this time, Evotec SE's Property Plant And Equipment Net is very stable compared to the past year. As of the 5th of August 2025, Current Deferred Revenue is likely to grow to about 115.3 M, while Other Assets are likely to drop 1.09.

Total Assets Total Stockholder Equity Other Assets Common Stock Shares Outstanding

Add Fundamental

Total Assets

Total assets refers to the total amount of Evotec SE assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Evotec SE ADR books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Most accounts from Evotec SE's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Evotec SE ADR current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evotec SE ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

	2022	2023	2024	2025 (projected)
Total Stockholder Equity	1.2B	1.1B	952.5M	1.0B
Total Assets	2.3B	2.3B	1.9B	2.0B

Total Stockholder Equity Total Assets

Evotec SE balance sheet Correlations

	Total Assets	Total Stockholder Equity	Other Assets	Common Stock Shares Outstanding	Other Stockholder Equity	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Receivables	Inventory
Total Assets		0.99	-0.66	0.41	0.86	0.96	0.95	0.95	0.93	0.98	0.34	0.14	0.95	0.88	0.99	0.83	0.89	0.66	0.97	0.8	0.99	0.98	0.36	0.66	0.95	0.94
Total Stockholder Equity	0.99		-0.59	0.43	0.87	0.92	0.91	0.92	0.9	0.97	0.19	0.19	0.92	0.91	0.96	0.82	0.92	0.7	0.92	0.82	0.94	0.99	0.32	0.65	0.91	0.92
Other Assets	-0.66	-0.59		0.04	-0.45	-0.59	-0.7	-0.69	-0.84	-0.65	-0.63	0.07	-0.79	-0.31	-0.71	-0.58	-0.37	-0.46	-0.71	-0.55	-0.72	-0.56	-0.2	-0.2	-0.82	-0.82
Common Stock Shares Outstanding	0.41	0.43	0.04		0.68	0.37	0.46	0.36	0.26	0.44	0.07	-0.38	0.26	0.41	0.38	0.23	0.45	0.42	0.37	0.42	0.38	0.43	0.08	0.86	0.37	0.18
Other Stockholder Equity	0.86	0.87	-0.45	0.68		0.79	0.78	0.82	0.76	0.82	0.16	-0.09	0.82	0.83	0.83	0.79	0.85	0.65	0.79	0.78	0.82	0.86	0.39	0.89	0.78	0.72
Short Long Term Debt Total	0.96	0.92	-0.59	0.37	0.79		0.91	0.91	0.87	0.92	0.47	0.19	0.89	0.88	0.95	0.8	0.86	0.54	0.98	0.71	0.98	0.93	0.38	0.63	0.89	0.87
Other Current Liab	0.95	0.91	-0.7	0.46	0.78	0.91		0.95	0.92	0.93	0.51	-0.01	0.9	0.73	0.97	0.72	0.74	0.55	0.93	0.7	0.96	0.87	0.41	0.65	0.94	0.9
Total Current Liabilities	0.95	0.92	-0.69	0.36	0.82	0.91	0.95		0.91	0.91	0.45	0.04	0.96	0.77	0.97	0.81	0.76	0.52	0.89	0.74	0.95	0.87	0.6	0.66	0.91	0.91
Property Plant And Equipment Net	0.93	0.9	-0.84	0.26	0.76	0.87	0.92	0.91		0.91	0.47	-0.04	0.95	0.69	0.96	0.75	0.71	0.54	0.93	0.66	0.94	0.86	0.3	0.53	0.95	0.97
Current Deferred Revenue	0.98	0.97	-0.65	0.44	0.82	0.92	0.93	0.91	0.91		0.32	0.16	0.91	0.84	0.96	0.8	0.87	0.68	0.95	0.81	0.96	0.96	0.24	0.63	0.95	0.91
Net Debt	0.34	0.19	-0.63	0.07	0.16	0.47	0.51	0.45	0.47	0.32		-0.25	0.41	0.02	0.44	0.26	0.02	0.02	0.49	0.15	0.49	0.19	0.34	0.19	0.51	0.39
Retained Earnings	0.14	0.19	0.07	-0.38	-0.09	0.19	-0.01	0.04	-0.04	0.16	-0.25		0.04	0.38	0.06	0.19	0.38	0.25	0.12	0.3	0.09	0.25	-0.05	-0.36	0.05	0.15
Accounts Payable	0.95	0.92	-0.79	0.26	0.82	0.89	0.9	0.96	0.95	0.91	0.41	0.04		0.77	0.96	0.87	0.78	0.6	0.91	0.78	0.95	0.89	0.46	0.6	0.93	0.94
Cash	0.88	0.91	-0.31	0.41	0.83	0.88	0.73	0.77	0.69	0.84	0.02	0.38	0.77		0.81	0.79	0.98	0.61	0.83	0.74	0.83	0.93	0.29	0.64	0.71	0.73
Non Current Assets Total	0.99	0.96	-0.71	0.38	0.83	0.95	0.97	0.97	0.96	0.96	0.44	0.06	0.96	0.81		0.81	0.81	0.56	0.96	0.74	0.99	0.93	0.42	0.65	0.95	0.94
Non Currrent Assets Other	0.83	0.82	-0.58	0.23	0.79	0.8	0.72	0.81	0.75	0.8	0.26	0.19	0.87	0.79	0.81		0.81	0.64	0.8	0.79	0.82	0.83	0.41	0.57	0.76	0.77
Cash And Short Term Investments	0.89	0.92	-0.37	0.45	0.85	0.86	0.74	0.76	0.71	0.87	0.02	0.38	0.78	0.98	0.81	0.81		0.76	0.84	0.85	0.83	0.96	0.22	0.64	0.77	0.75
Short Term Investments	0.66	0.7	-0.46	0.42	0.65	0.54	0.55	0.52	0.54	0.68	0.02	0.25	0.6	0.61	0.56	0.64	0.76		0.61	0.91	0.6	0.75	-0.05	0.45	0.7	0.61
Non Current Liabilities Total	0.97	0.92	-0.71	0.37	0.79	0.98	0.93	0.89	0.93	0.95	0.49	0.12	0.91	0.83	0.96	0.8	0.84	0.61		0.74	0.99	0.94	0.25	0.61	0.95	0.91
Other Current Assets	0.8	0.82	-0.55	0.42	0.78	0.71	0.7	0.74	0.66	0.81	0.15	0.3	0.78	0.74	0.74	0.79	0.85	0.91	0.74		0.76	0.85	0.27	0.57	0.8	0.72
Total Liab	0.99	0.94	-0.72	0.38	0.82	0.98	0.96	0.95	0.94	0.96	0.49	0.09	0.95	0.83	0.99	0.82	0.83	0.6	0.99	0.76		0.94	0.38	0.64	0.96	0.93
Total Current Assets	0.98	0.99	-0.56	0.43	0.86	0.93	0.87	0.87	0.86	0.96	0.19	0.25	0.89	0.93	0.93	0.83	0.96	0.75	0.94	0.85	0.94		0.25	0.65	0.9	0.89
Short Term Debt	0.36	0.32	-0.2	0.08	0.39	0.38	0.41	0.6	0.3	0.24	0.34	-0.05	0.46	0.29	0.42	0.41	0.22	-0.05	0.25	0.27	0.38	0.25		0.39	0.28	0.32
Common Stock	0.66	0.65	-0.2	0.86	0.89	0.63	0.65	0.66	0.53	0.63	0.19	-0.36	0.6	0.64	0.65	0.57	0.64	0.45	0.61	0.57	0.64	0.65	0.39		0.57	0.43
Net Receivables	0.95	0.91	-0.82	0.37	0.78	0.89	0.94	0.91	0.95	0.95	0.51	0.05	0.93	0.71	0.95	0.76	0.77	0.7	0.95	0.8	0.96	0.9	0.28	0.57		0.95
Inventory	0.94	0.92	-0.82	0.18	0.72	0.87	0.9	0.91	0.97	0.91	0.39	0.15	0.94	0.73	0.94	0.77	0.75	0.61	0.91	0.72	0.93	0.89	0.32	0.43	0.95

Click cells to compare fundamentals

Evotec SE Account Relationship Matchups

Evotec SE balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	1.5B	2.2B	2.3B	2.3B	1.9B	2.0B
Total Stockholder Equity	724.5M	1.4B	1.2B	1.1B	952.5M	1.0B
Other Assets	58.0M	62.3M	79.3M	1.0	1.15	1.09
Common Stock Shares Outstanding	307.5M	332.8M	353.4M	176.9M	354.6M	222.1M
Liabilities And Stockholders Equity	1.5B	2.2B	2.3B	2.3B	1.9B	2.0B
Other Stockholder Equity	1.0B	1.4B	1.4B	1.4B	1.5B	804.0M
Short Long Term Debt Total	492.0M	512.9M	506.7M	626.2M	443.5M	465.7M
Other Current Liab	61.9M	63.9M	78.4M	73.3M	84.2M	88.4M
Total Current Liabilities	208.5M	324.5M	337.7M	464.6M	344.6M	361.8M
Property Plant And Equipment Net	337.3M	484.6M	650.2M	806.6M	823.9M	865.1M
Current Deferred Revenue	70.6M	126.8M	136.7M	107.9M	109.8M	115.3M
Net Debt	69.4M	(186.4M)	91.5M	115.3M	137.2M	144.0M
Retained Earnings	(434.2M)	(216.4M)	(392.4M)	(476.3M)	(672.4M)	(706.0M)
Accounts Payable	42.5M	72.6M	97.3M	134.3M	85.8M	90.1M
Cash	422.6M	699.3M	415.2M	510.9M	306.4M	168.6M
Non Current Assets Total	803.5M	1.1B	1.2B	1.4B	1.2B	1.3B
Non Currrent Assets Other	37.4M	56.8M	74.1M	95.2M	37.8M	33.2M
Cash And Short Term Investments	492.2M	858.5M	730.0M	604.1M	396.8M	238.6M
Short Term Investments	70.1M	159.2M	314.8M	93.2M	90.4M	75.7M
Non Current Liabilities Total	529.4M	533.0M	732.4M	714.6M	615.4M	646.2M
Other Current Assets	30.4M	63.6M	123.0M	64.1M	35.7M	23.8M
Total Liab	737.9M	857.5M	1.1B	1.2B	960.0M	1.0B
Total Current Assets	658.8M	1.1B	1.1B	903.2M	682.0M	716.1M
Short Term Debt	30.0M	50.6M	16.4M	149.1M	50.8M	33.3M
Common Stock	163.9M	176.6M	177.0M	177.2M	177.6M	131.2M
Net Receivables	100.5M	153.3M	275.8M	204.1M	218.4M	229.3M
Inventory	13.6M	25.8M	29.8M	30.9M	31.1M	32.7M
Good Will	247.4M	257.6M	274.8M	275.6M	282.9M	144.0M
Accumulated Other Comprehensive Income	(37.5M)	(12.6M)	(37.4M)	(30.6M)	(7.3M)	(7.7M)
Intangible Assets	98.0M	30.9M	23.8M	15.5M	26.4M	25.1M
Other Liab	93.2M	82.6M	69.6M	70.7M	63.6M	61.8M
Net Tangible Assets	79.0M	102.9M	375.9M	1.1B	1.3B	1.3B
Long Term Debt	331.0M	326.3M	328.3M	307.1M	392.7M	286.7M
Capital Lease Obligations	145.6M	150.4M	176.8M	189.1M	217.5M	125.8M
Net Invested Capital	1.1B	1.7B	1.5B	1.1B	1.4B	1.2B
Short Long Term Debt	15.4M	36.1M	1.6M	130.0M	50.8M	46.3M
Net Working Capital	450.4M	776.4M	736.0M	438.6M	337.4M	414.9M
Property Plant Equipment	89.3M	238.0M	335.7M	484.6M	557.3M	585.2M
Long Term Investments	59.0M	287.0M	150.3M	142.1M	42.2M	40.0M
Capital Stock	163.9M	176.6M	177.0M	177.2M	177.6M	184.2M

Pair Trading with Evotec SE

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evotec SE position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evotec SE will appreciate offsetting losses from the drop in the long position's value.

The ability to find closely correlated positions to Evotec SE could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Evotec SE when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Evotec SE - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Evotec SE ADR to buy it.

The correlation of Evotec SE is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Evotec SE moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Evotec SE ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Evotec SE can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Evotec SE ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evotec SE's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evotec Se Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evotec Se Adr Stock:

How To Invest In Evotec

Details

Is Evotec Stock a good investment?

Details

What is Evotec SE's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evotec SE. If investors know Evotec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evotec SE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.67)

Revenue Per Share

2.222

Quarterly Revenue Growth

(0.04)

Return On Assets

(0.02)

Return On Equity

(0.21)

The market value of Evotec SE ADR is measured differently than its book value, which is the value of Evotec that is recorded on the company's balance sheet. Investors also form their own opinion of Evotec SE's value that differs from its market value or its book value, called intrinsic value, which is Evotec SE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evotec SE's market value can be influenced by many factors that don't directly affect Evotec SE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Evotec SE's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evotec SE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evotec SE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

Evotec Historical Balance Sheet

Evotec SE Inventory

32.68 Million

About Evotec Balance Sheet Analysis

Evotec SE Balance Sheet Chart

Total Assets

Total Stockholder Equity

Common Stock Shares Outstanding

Evotec SE balance sheet Correlations

Evotec SE Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Evotec SE balance sheet Accounts

Pair Trading with Evotec SE

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Total Assets
Total Liab	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Stockholder Equity
Total Liab	+ 0.99	Non Current Assets Total
Total Liab	+ 0.99	Non Current Liabilities Total

Property Plant And Equipment Net	- 0.84	Other Assets
Inventory	- 0.82	Other Assets
Net Receivables	- 0.82	Other Assets
Accounts Payable	- 0.79	Other Assets
Total Liab	- 0.72	Other Assets
Non Current Liabilities Total	- 0.71	Other Assets